EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAFII68, and Subunits of TFIID and RNA Polymerase II Complexes

ABSTRACT The t(11;22) chromosomal translocation specifically linked to Ewing sarcoma and primitive neuroectodermal tumor results in a chimeric molecule fusing the amino-terminus-encoding region of theEWS gene to the carboxyl-terminal DNA-binding domain encoded by the FLI-1 gene. As the function of the protein encoded by the EWS gene remains unknown, we investigated the putative role of EWS in RNA polymerase II (Pol II) transcription by comparing its activity with that of its structural homolog, hTAFII68. We demonstrate that a portion of EWS is able to associate with the basal transcription factor TFIID, which is composed of the TATA-binding protein (TBP) and TBP-associated factors (TAFIIs). In vitro binding studies revealed that both EWS and hTAFII68 interact with the same TFIID subunits, suggesting that the presence of EWS and that of hTAFII68 in the same TFIID complex may be mutually exclusive. Moreover, EWS is not exclusively associated with TFIID but, similarly to hTAFII68, is also associated with the Pol II complex. The subunits of Pol II that interact with EWS and hTAFII68 have been identified, confirming the association with the polymerase. In contrast to EWS, the tumorigenic EWS–FLI-1 fusion protein is not associated with either TFIID or Pol II in Ewing cell nuclear extracts. These observations suggest that EWS and EWS–FLI-1 may play different roles in Pol II transcription.

[1]  C. Denny,et al.  Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Thiery,et al.  Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). , 1988, Cancer genetics and cytogenetics.

[3]  M. Ladanyi.  The emerging molecular genetics of sarcoma translocations. , 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[4]  C. Burd,et al.  Conserved structures and diversity of functions of RNA-binding proteins. , 1994, Science.

[5]  B. Wasylyk,et al.  The Ets family of transcription factors. , 1993, European journal of biochemistry.

[6]  B. Lewin.  Oncogenic conversion by regulatory changes in transcription factors , 1991, Cell.

[7]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[8]  V C Emery,et al.  Baculovirus expression vectors. , 1991, Methods in molecular biology.

[9]  H. Zinszner,et al.  A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. , 1994, Genes & development.

[10]  R. Tjian,et al.  TAFs mediate transcriptional activation and promoter selectivity. , 1996, Trends in biochemical sciences.

[11]  N. Mandahl,et al.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.

[12]  E. Reddy,et al.  EWS/Fli-1 chimeric protein is a transcriptional activator. , 1993, Cancer research.

[13]  S. Hiebert,et al.  Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. , 1995, Critical reviews in eukaryotic gene expression.

[14]  H. Hurst.  Transcription factors as drug targets in cancer. , 1996, European journal of cancer.

[15]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[16]  M. Vigneron,et al.  Synthesis and maturation of viral transcripts in herpes simplex virus type 1 infected HeLa cells: the role of interchromatin granules. , 1995, Gene expression.

[17]  D. Stolow,et al.  Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. , 1995, Nucleic acids research.

[18]  Thorner,et al.  Immunophilins in the Yeast Saccharomyces cerevisiae: A Different Spin on Proline Rotamases , 1996, Methods.

[19]  R. Roeder.  Nuclear RNA polymerases: role of general initiation factors and cofactors in eukaryotic transcription. , 1996, Methods in enzymology.

[20]  J. Acker,et al.  Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex. , 1996, The EMBO journal.

[21]  T. Melot,et al.  Production and characterization of mouse monoclonal antibodies to wild-type and oncogenic FLI-1 proteins. , 1997, Hybridoma.

[22]  C. Denny,et al.  Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. , 1995, Oncogene.

[23]  P. Chambon,et al.  Distinct TFIID complexes mediate the effect of different transcriptional activators. , 1993, The EMBO journal.

[24]  X. Jacq,et al.  Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor , 1994, Cell.

[25]  G. Thomas,et al.  Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. , 1995, Human molecular genetics.

[26]  P. Chambon,et al.  hTAF(II)68, a novel RNA/ssDNA‐binding protein with homology to the pro‐oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. , 1996, The EMBO journal.

[27]  G. Thomas,et al.  Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. , 1993, Genomics.

[28]  J. Hata,et al.  A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. , 1996, Biochemical and biophysical research communications.

[29]  P. Chambon,et al.  Purification and interaction properties of the human RNA polymerase B(II) general transcription factor BTF2. , 1991, The Journal of biological chemistry.

[30]  R. Larson,et al.  Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.

[31]  D. Bentley,et al.  Transcriptional elongation by RNA polymerase II is stimulated by transactivators , 1994, Cell.

[32]  P. Evans,et al.  Crystal structure of the RNA-binding domain of the U1 small nuclear ribonucleoprotein A , 1990, Nature.

[33]  G. Evans,et al.  EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. , 1994, The Journal of clinical investigation.

[34]  M. Roussel,et al.  DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma , 1994, Molecular and cellular biology.

[35]  G. Thomas,et al.  A new member of the ETS family fused to EWS in Ewing tumors , 1997, Oncogene.

[36]  M. Ouchida,et al.  The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. , 1994, Oncogene.

[37]  J. Acker,et al.  Interactions between the Human RNA Polymerase II Subunits* , 1997, The Journal of Biological Chemistry.

[38]  P. Chambon,et al.  SUG1, a Putative Transcriptional Mediator and Subunit of the PA700 Proteasome Regulatory Complex, Is a DNA Helicase* , 1997, The Journal of Biological Chemistry.

[39]  D. Immanuel,et al.  Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II , 1995, Molecular and cellular biology.